Ocular Inflammation Treatment Market

Eye inflammations or uveitis are becoming a common problem for people across global geographies. New drugs are being discovered to treat ocular inflammations, and companies are investing millions for their approval through regulatory pipelines. Patients are exhibiting a particular preference to the type of ocular inflammation treatment being adopted, considering the range of treatment options, their comparative effectiveness, and convenience in terms of mode of administration.
Ocular Inflammation Treatment Market contains market size and forecasts of Ocular Inflammation Treatment in Global, including the following market information:
Global Ocular Inflammation Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Ocular Inflammation Treatment market was valued at 20810 million in 2021 and is projected to reach US$ 29840 million by 2028, at a CAGR of 5.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Immunosuppressant Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Ocular Inflammation Treatment include Allergan, Cipla, Pfizer, Novartis, Valeant Pharmaceuticals International, Alimera Sciences, Akorn, Abbvie and Eyegate Pharmaceuticals and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Ocular Inflammation Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ocular Inflammation Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Ocular Inflammation Treatment Market Segment Percentages, by Type, 2021 (%)
Immunosuppressant
Monoclonal Antibodies
Corticosteroids
Cycloplegic Agents
Antibiotics
Analgesics
Antivirals
Antifungal
Global Ocular Inflammation Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Ocular Inflammation Treatment Market Segment Percentages, by Application, 2021 (%)
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Drug Stores
Global Ocular Inflammation Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Ocular Inflammation Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ocular Inflammation Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Ocular Inflammation Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan
Cipla
Pfizer
Novartis
Valeant Pharmaceuticals International
Alimera Sciences
Akorn
Abbvie
Eyegate Pharmaceuticals
pSivida